glp 1 drugs and thyroid cancer Increased GLP-1 Risks May Be Product of More Intense Screening, Study Finds Does GLP 1 drug affect

The Mechanisms of Semaglutide Therapy in Heart Failure Patients trial will assess the impact of semaglutide on biomarkers, echocardiographic parameters, and functional outcomes in patients with HF [63]

JAMA Cardiol 2:10251029 Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, CREDENCE Trial Investigators et al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

Losing weight helps reduce what used to be called non-alcoholic fatty liver disease and is now known as metabolic dysfunction-associated steatotic liver disease or MASLD

doi: 10.1111/liv.14385

By tracking biomarkers like glucose, cholesterol, and kidney function, you and your healthcare provider can ensure your path to weight loss is both effective and safe

This study demonstrates the noninferiority of albiglutide treatment with respect to glycemic control